← All organizations
Highest phase reached
Phase 3
First clinical trial
Sep 1, 2010Last known activity
Oct 31, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (4 distinct, 3 trials)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Recent trials (3)
- NCT06585020CollaboratorPhase 2Oct 31, 2024
- NCT03083184CollaboratorPhase 3Apr 1, 2017
- NCT01380028CollaboratorPhase 3Sep 1, 2010
Details
- Last known activity
- Oct 31, 2024